Foresite Capital — 2025 Investments
5 investments dated 2025 · listed companies and verified rows first · show all
BiotechHayward, US
Roger M. Perlmutter(Executive Officer, Director)
BoardJoshua Wolfe(Director)inDror Berman(Director)Leon Chen(Director)Adam Goulburn(Director)in
Board seatJames Tananbaum· per SEC Form D
Co-investorsLux CapitalDimension Capital
Latigo Bio is a clinical-stage biopharmaceutical company developing non-opioid pain medicines intended to block pain transmission without addiction risk.
BiotechHealthtechThousand Oaks, US
Nima Farzan(Executive Officer, Director)Tim Lugo(Executive Officer)
BoardBeth Seidenberg(Director)inJim Tananbaum(Director)Deborah Palestrant(Director)inKevin Raidy(Director)
Co-investorsAccess BiotechnologyKern Capital, LLCSanofi Ventures5AM VenturesWestlake Village BioPartners
Mirvie develops an RNA-based platform for early detection of pregnancy complications, enabling proactive intervention before complications become critical.
BiotechFemTechHealthtechSouth San Francisco, US
Maneesh Jain(Executive Officer, Director, Promoter)inStephen Quake(Director)
BoardLisa Iverson(Director)Ursheet Parikh(Director)inMin Cui(Director)inSamir Kaul(Director)in
Co-investorsDecheng CapitalMayfield FundPortfoliaGeneral CatalystKhosla Ventures
Thyme has partnered with Altruist to create Hazel, an AI product for wealth management professionals.
AI & Machine LearningEnterprise SoftwareFintechSan Francisco, US
Daniel Lantz(Founder)inFernando San Martin(Founder)in
Co-investorsY CombinatorAlleyCorpConcord Health PartnersCVS Health VenturesFrist Cressey VenturesHumana+1 more
Thyme Care develops software to enhance care coordination and outcomes for cancer patients.
Digital HealthHealthtechNashville, US
Robert Green(Executive Officer, Director)Robin Shah(Executive Officer, Director)inBobby Green(Founder)in
BoardBrian Belsky(Director)inElizabeth Canis(Director)inBrenton Fargnoli(Director)in
Co-investorsAlleyCorpAndreessen HorowitzCorewell Health VenturesCVS Health VenturesEcho Health VenturesFrist Cressey Ventures+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.